InMed Pharmaceuticals (INM) vs cbdMD (YCBD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
InMed Pharmaceuticals is the larger company by market cap ($7.3 million vs $4.4 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INM | YCBD |
|---|---|---|
| Share price | $1.33 | $0.3948 |
| Market cap | $7.31M | $4.42M |
| 1-day change | 0.00% | -3.00% |
| P/E ratio (TTM) | — | 1.72 |
| EPS (TTM) | $-2.84 | $0.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.40 | $2.56 |
| 52-week low | $0.575 | $0.38 |
| Distance from 52-week high | -44.58% | -84.58% |
| Analyst consensus | — | none |
| Average volume | 914.23K | 433.66K |
| Shares outstanding | 5.49M | 11.21M |
| Employees | 6 | 42 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: InMed Pharmaceuticals in Health Care and cbdMD in Consumer Discretionary.
About InMed Pharmaceuticals
INM stock →InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
About cbdMD
YCBD stock →cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally.
Consumer Discretionary · Package Goods/Cosmetics · 42 employees
INM vs YCBD FAQ
Which is bigger, InMed Pharmaceuticals or cbdMD?
InMed Pharmaceuticals (INM) is larger, with a market capitalization of $7.31M compared with $4.42M for cbdMD (YCBD).
Are InMed Pharmaceuticals and cbdMD in the same industry?
No. InMed Pharmaceuticals is in the Health Care sector, while cbdMD is in Consumer Discretionary.